Successful i-GONAD in Mice at Early Zygote Stage through In Vivo Electroporation Three Min after Intraoviductal Instillation of CRISPR-Ribonucleoprotein
Open Access
- 14 September 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (18) , 10678
Abstract
Improved genome editing via oviductal nucleic acids delivery (i-GONAD) is a new technology enabling in situ genome editing of mammalian zygotes exiting the oviductal lumen, which is now available in mice, rats, and hamsters. In this method, CRISPR/Cas9 genome-editing reagents are delivered directly to the oviducts of pregnant animals (corresponding to late zygote stage). After intraoviductal instillation, electric shock to the entire oviduct was provided with a specialized electroporation (EP) device to drive the genome editing reagents into the zygotes present in the oviductal lumen. i-GONAD toward early zygotes has been recognized as difficult, because they are tightly surrounded by a cumulus cell layer, which often hampers effective transfer of nucleic acids to zygotes. However, in vivo EP three min after intraoviductal instillation of the genome-editing reagents enabled genome editing of early zygotes with an efficiency of 70%, which was in contrast with the rate of 18% when in vivo EP was performed immediately after intraoviductal instillation at Day 0.5 of pregnancy (corresponding to 13:00–13:30 p.m. on the day when vaginal plug was recognized after natural mating). We also found that addition of hyaluronidase, an enzyme capable of removing cumulus cells from a zygote, slightly enhanced the efficiency of genome editing in early zygotes. These findings suggest that cumulus cells surrounding a zygote can be a barrier for efficient generation of genome-edited mouse embryos and indicate that a three-minute interval before in vivo EP is effective for achieving i-GONAD-mediated genome editing at the early zygote stage. These results are particularly beneficial for researchers who want to perform genome editing experiments targeting early zygotes.Keywords
Funding Information
- Japan Society for the Promotion of Science (21K05890)
This publication has 11 references indexed in Scilit:
- Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONADNature Protocols, 2019
- i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleasesGenome Biology, 2018
- GONAD: Genome-editing via Oviductal Nucleic Acids Delivery system: a novel microinjection independent genome engineering method in miceScientific Reports, 2015
- Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotesDevelopmental Biology, 2014
- Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineeringScientific Reports, 2014
- Generation of mutant mice by pronuclear injection of circular plasmid expressing Cas9 and single guided RNAScientific Reports, 2013
- One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- In vivogene transfer in mouse preimplantation embryos after intraoviductal injection of plasmid DNA and subsequentin vivoelectroporationSystems Biology in Reproductive Medicine, 2012
- Intraoviductal introduction of plasmid DNA and subsequent electroporation for efficient in vivo gene transfer to murine oviductal epitheliumMolecular Reproduction and Development, 2005